Kaili Yang

Statistics

Publications

Citations

158

H-Index

Active since

2020

Affiliations

Peking Union Medical College Hospital(Current)

Chinese Academy of Medical Sciences & Peking Union Medical College

Peking University

Kaili Yang is an author at Peking Union Medical College Hospital specializing in oncology, checkpoint inhibitor therapy, and immune checkpoint inhibitors.

ORCID

Publications per year

2020–2023

Publications

Pan-Asian adaptation of the EHNS–ESMO–ESTRO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with squamous cell carcinoma of the head and neck

Bhumsuk Keam, Jean-Pascal Machiels, Hye Ryun Kim et al. · ESMO Open · 2021 · 82 citations · Full text

Medicine, Oncology, Cancer Control +14

Real-world outcomes of regorafenib combined with immune checkpoint inhibitors in patients with advanced or metastatic microsatellite stable colorectal cancer: A multicenter study

Kaili Yang, Lu Han, Shikai Wu et al. · Cancer Immunology Immunotherapy · 2021 · 29 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Effect of age on the risk of immune-related adverse events in patients receiving immune checkpoint inhibitors

Kaili Yang, Jiarui Li, Zhao Sun et al. · Clinical and Experimental Medicine · 2023 · 24 citations

Life Sciences, Immunology, Oncology +14

Impact of corticosteroids use on efficacy of immune checkpoint inhibitors in cancer patients: A meta-analysis.

Jiarui Li, Kaili Yang, Lin Zhao et al. · Journal of Clinical Oncology · 2020 · 12 citations

Medicine, Oncology, Pharmacology +17

Estimating the number of Chinese cancer patients eligible for and benefit from immune checkpoint inhibitors

Kaili Yang, Jiarui Li, Lin Zhao et al. · Frontiers of Medicine · 2022 · 11 citations

Life Sciences, Immunology, Oncology +13

1–5 of 5